Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06084676 · ClinicalTrials.gov registry record
Organoid Model Predictive of Response to Immunotherapies
A clinical trial, sponsored by Indiana University.
- Terminated
- Registry status
- 1
- Enrollment target
NCT06084676: Clinical Trial study, sponsored by Indiana University.
NCT06084676 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06084676 was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to create models out of tissue samples and treat those models with the same immunotherapy treatment the patient will be receiving, in order to validate this process and to predict responses to therapies and use it to choose the best treatments for people in the future. The researchers will then examine the direct effects of the treatment on those models.
Primary Outcome
Compare patient response using RECIST 1.1 criteria and immune-organoid response based on the following criteria: 1. Complete response \<50% of viable tumor cells 2. Response \>50%\<70% of viable tumor cells 3. Stable \>70%\<90% viable tumor cell left 4. Progressive \>90% of viable tumor cell left
Interventions
- DRUG Immunotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2024-01-22 |
| Est. Completion | 2024-02-26 |
Why NCT06084676 stopped before completion
NCT06084676 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Immunotherapy is the first listed.
NCT06084676 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06084676 about?
NCT06084676 is a clinical study titled "Organoid Model Predictive of Response to Immunotherapies". The purpose of this study is to create models out of tissue samples and treat those models with the same immunotherapy treatment the patient will be receiving, in order to validate this process and to predict responses to therapies and use it to choose the best treatments for people in the future. T...
What is the current status of trial NCT06084676?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2024-01-22. Estimated completion is 2024-02-26.
What interventions are being tested in trial NCT06084676?
The interventions under investigation include: Immunotherapy (DRUG).
Who is sponsoring clinical trial NCT06084676?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI